From a single biotech with one target to a global portfolio team. Every license is scoped to your targets, markets and team — so pricing fits the value, not a list. Talk to us and we’ll put together a proposal.
Small biotech · single asset · local pilot
Mid pharma · regional EMEA team
Global pharma · portfolio & CI teams
Three license tiers, plus à-la-carte intelligence. We scope the right fit in a short discovery call — no list price, because every engagement is tailored to your targets, markets and team.
Commission a single piece of intelligence — often the fastest way to start.
Bespoke landscape on a target, molecule, country or competitive segment.
Structured trial page + targeted promotion to relevant centres, per campaign.
Multilingual editorial dossier; declared sponsorship, editorial independence.
Co-produced webinar with named KOLs; live + replay; engagement data.
Scope varies widely — targets, countries, seats, API and advisory. We price to the value of your specific use case, which is faster to get right in a short call than from a list.
Annual, auto-renewing, with a multi-year discount. Founding-partner terms are available for early reference clients.
Refreshed on a defined cadence by tier; high-stakes fields are human-verified. See Data & Methodology in Insights.
Public-source provenance, no patient data, GDPR and MDR/EFPIA-aware — documented to speed review.
Tell us your targets and markets; we’ll recommend the right tier and put together a proposal.
Contact salesGet a sample report